Header Logo

Connection

Nicola Klein to Immunization

This is a "connection" page, showing publications Nicola Klein has written about Immunization.
Connection Strength

4.512
  1. Informing Maternal Immunization Trials: An Observational Study to Assess Background Rates of Maternal, Pregnancy, and Neonatal/Infant Outcomes. Pediatr Infect Dis J. 2025 Feb 01; 44(2S):S130-S134.
    View in: PubMed
    Score: 0.923
  2. Differentiating Sepsis From Adverse Events After Immunization in the Neonatal Intensive Care Unit: How Is a Physician to Know? JAMA Pediatr. 2015 Aug; 169(8):718-9.
    View in: PubMed
    Score: 0.478
  3. Effect of age on the risk of Fever and seizures following immunization with measles-containing vaccines in children. JAMA Pediatr. 2013 Dec; 167(12):1111-7.
    View in: PubMed
    Score: 0.426
  4. Comprehensive assessment of serious adverse events following immunization by health care providers. J Pediatr. 2013 Jun; 162(6):1276-81, 1281.e1.
    View in: PubMed
    Score: 0.404
  5. Evaluation of immunization rates and safety among children with inborn errors of metabolism. Pediatrics. 2011 May; 127(5):e1139-46.
    View in: PubMed
    Score: 0.354
  6. Risk of fever and sepsis evaluations after routine immunizations in the neonatal intensive care unit. J Perinatol. 2010 Sep; 30(9):604-9.
    View in: PubMed
    Score: 0.328
  7. Risk factors for developing apnea after immunization in the neonatal intensive care unit. Pediatrics. 2008 Mar; 121(3):463-9.
    View in: PubMed
    Score: 0.286
  8. All Older Adults Benefit From Pneumococcal Vaccinations-The Case for Evaluating Vaccine Effectiveness Using All-Cause Pneumonia. JAMA Intern Med. 2023 01 01; 183(1):48-49.
    View in: PubMed
    Score: 0.200
  9. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021. MMWR Morb Mortal Wkly Rep. 2021 Aug 13; 70(32):1094-1099.
    View in: PubMed
    Score: 0.181
  10. Chorioamnionitis: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2019 12 10; 37(52):7610-7622.
    View in: PubMed
    Score: 0.162
  11. Elimination of Nonmedical Immunization Exemptions in California and School-Entry Vaccine Status. Pediatrics. 2019 06; 143(6).
    View in: PubMed
    Score: 0.155
  12. Patterns of childhood immunization and all-cause mortality. Vaccine. 2017 12 04; 35(48 Pt B):6643-6648.
    View in: PubMed
    Score: 0.139
  13. Biologically plausible and evidence-based risk intervals in immunization safety research. Vaccine. 2012 Dec 17; 31(1):271-7.
    View in: PubMed
    Score: 0.097
  14. Algorithm to assess causality after individual adverse events following immunizations. Vaccine. 2012 Aug 24; 30(39):5791-8.
    View in: PubMed
    Score: 0.095
  15. Overview of the Clinical Consult Case Review of adverse events following immunization: Clinical Immunization Safety Assessment (CISA) network 2004-2009. Vaccine. 2011 Sep 16; 29(40):6920-7.
    View in: PubMed
    Score: 0.090
  16. Vaccine safety in special populations. Hum Vaccin. 2011 Feb; 7(2):269-71.
    View in: PubMed
    Score: 0.087
  17. Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2021 05 21; 39(22):3037-3049.
    View in: PubMed
    Score: 0.044
  18. Sensorineural hearing loss (SNHL) as an adverse event following immunization (AEFI): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2020 06 19; 38(30):4717-4731.
    View in: PubMed
    Score: 0.042
  19. Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network. Pediatrics. 2011 May; 127 Suppl 1:S65-73.
    View in: PubMed
    Score: 0.022

© 2025 Kaiser Permanente